← Evidence map

ReviewTherapeutic innovation & regulatory science2026

Current Status and Construction Requirements of Drug Clinical Trial Institutions in Sichuan Province in China.

Shuxia Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42373933